PFIZER TKN 250 (Tikosyn 0.25 MG)
Generic Name: dofetilide
Pill imprint PFIZER TKN 250 has been identified as Tikosyn 0.25 MG.
Tikosyn is used in the treatment of arrhythmia and belongs to the drug class group III antiarrhythmics. Risk cannot be ruled out during pregnancy. Tikosyn 0.25 MG is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- dofetilide
- Imprint:
- PFIZER TKN 250
- Strength:
- 0.25 MG
- Color:
- Orange
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Group III antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00069-5810
- Inactive Ingredients:
- microcrystalline cellulose
corn starch
silicon dioxide
magnesium stearate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 59762-0038 | Greenstone LLC |
Note: Inactive ingredients may vary.
More about Tikosyn (dofetilide)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
